Bankruptcy leaves indigenous sickle cell treatment in jeopardy
Friday, November 21, 2008 - 13:28
in Health & Medicine
Xechem International, the US-based company that owns the rights to a promising sickle cell anaemia treatment, has filed for bankruptcy.